VolitionRx Limited Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
VolitionRx Limited (VNRX) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of -$33.54 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$33.54M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$33.36M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$35.59M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$35.95M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | -$33.54M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$33.36M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | -$35.59M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$35.95M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$33.10M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$29.03M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | -$26.11M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | -$22.64M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$22.90M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | -$16.62M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | -$8.71M 10-K · filed 2026-03-31 | |
| 2023-09-30 | -$2.85M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $5.12M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | -$2.98M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | -$3.13M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $2.84M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $4.08M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $10.81M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $17.72M 10-K · filed 2024-03-25 | |
| 2021-09-30 | $21.33M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $26.63M 10-Q · filed 2022-08-10 | $26.73M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $31.16M 10-Q · filed 2022-08-10 | $31.22M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $16.29M 10-Q · filed 2022-08-10 | $16.34M 10-K · filed 2021-03-22 |
| 2020-09-30 | $18.98M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $18.68M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $9.19M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $14.20M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |